Literature DB >> 11019997

Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma.

M Ebara1, H Fukuda, R Hatano, H Saisho, Y Nagato, K Suzuki, K Nakajima, M Yukawa, F Kondo, A Nakayama, H Sakurai.   

Abstract

BACKGROUND/AIM: Accumulation of copper (Cu) in hepatocellular carcinoma (HCC), especially in small tumors, is greater than that in the surrounding liver parenchyma. Metallothionein (MT) is considered to be present as Cu-MT, Zn,Cu-MT or Zn-MT. The aim of this study was to determine the presence and localization of Cu-MT and Zn-MT in HCC and surrounding liver parenchyma.
METHODS: In 16 HCC patients, surgically resected specimens including HCC and surrounding liver parenchyma were evaluated.
RESULTS: The level of Cu present in small HCC (<4 cm in diameter) was significantly greater than that in the surrounding liver parenchyma (p<0.05). However, the level of Cu in large HCC (>4 cm in diameter) was similar to that in the surrounding liver parenchyma. Analysis by Sephadex G-75 gel filtration revealed that the peak fraction due to Cu was identical to that due to MT in 14 (87.5%) of 16 HCC, the peak fraction due to Cu and Zn was identical to that due to MT in 2 (12.5%) HCC, and the peak fraction due to Zn was identical to that of MT in none of 16 HCC.
CONCLUSIONS: Accumulation of Cu in small HCC, in which Cu was present as Cu-MT or Zn, Cu-MT, was greater than that in the surrounding liver parenchyma. Cu accumulation and the presence of MT in the liver may be related to carcinogenesis of HCC, because of the similarity of these findings in the experimental data of Long-Evans rats with a cinnamon-like coat color who develop HCC spontaneously.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11019997     DOI: 10.1016/s0168-8278(00)80277-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  27 in total

Review 1.  Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Expert Rev Anticancer Ther       Date:  2012-01       Impact factor: 4.512

Review 2.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

3.  Anti-proliferative effect of pterostilbene on rat hepatoma cells in culture.

Authors:  Novi Indriana Dewi; Kazumi Yagasaki; Yutaka Miura
Journal:  Cytotechnology       Date:  2014-07-02       Impact factor: 2.058

4.  Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease.

Authors:  Mitsuhiko Moriyama; Hiroshi Matsumura; Akiko Fukushima; Kenji Ohkido; Yasuo Arakawa; Kazushige Nirei; Hiroaki Yamagami; Miki Kaneko; Naohide Tanaka; Yasuyuki Arakawa
Journal:  Dig Dis Sci       Date:  2006-10-18       Impact factor: 3.199

Review 5.  The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2014-01-21       Impact factor: 4.742

6.  Synthesis of fluorescent nanoprobe with simultaneous response to intracellular pH and Zn2+ for tumor cell distinguishment.

Authors:  Qin Wang; Yupeng Shi; Wandi Chen; Mo Yang; Changqing Yi
Journal:  Mikrochim Acta       Date:  2021-01-02       Impact factor: 5.833

Review 7.  Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer.

Authors:  S M Hadi; M F Ullah; A S Azmi; A Ahmad; U Shamim; H Zubair; H Y Khan
Journal:  Pharm Res       Date:  2010-01-30       Impact factor: 4.200

8.  ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer.

Authors:  Renty B Franklin; Bernard A Levy; Jing Zou; Nader Hanna; Mohamed Mokhtar Desouki; Omar Bagasra; Leslie A Johnson; Leslie C Costello
Journal:  J Gastrointest Cancer       Date:  2012-06

9.  DNA breakage induced by piceatannol and copper(II): Mechanism and anticancer properties.

Authors:  Zhensheng Li; Xiaozhan Yang; Shiwu Dong; Xiaohui Li
Journal:  Oncol Lett       Date:  2012-02-09       Impact factor: 2.967

Review 10.  Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.

Authors:  Mohammad Athar; Jung Ho Back; Levy Kopelovich; David R Bickers; Arianna L Kim
Journal:  Arch Biochem Biophys       Date:  2009-06-15       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.